(MENAFN- PR Newswire) PORT WASHINGTON, N.Y., Oct. 3, 2023 /PRNewswire/ -- EQUASHIELD®, a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, is thrilled to announce that ...

TEL AVIV, April 17 (Reuters) - Israeli medical device maker Equashield expects its sales to grow by more than 60 percent a year as more hospitals invest in its sealed syringes to protect healthcare ...

Equashield (http://www.equashield.com), the leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, today announced that The Journal of ...

PORT WASHINGTON, N.Y., Aug. 25, 2022 /PRNewswire/ -- Equashield, a leading provider of closed system transfer devices (CSTDs) for hazardous drugs, today announced that its state-of-the-art, automated ...

It’s been said that hospitals are a great place to get sick – not for those who are already ill (although they, too, risk exposure to all sorts of germs and viruses during their stay), but for the ...

PORT WASHINGTON, N.Y., Dec. 3, 2024 /PRNewswire/ -- EQUASHIELD ®, a leader in protecting healthcare workers through innovative compounding solutions and their closed system transfer device (CSTD), is ...

20% of Hospitals Now Investing in Closed System Transfer Devices to Prevent Exposure to Hazardous Drugs Equashield (http://www.equashield.com), the leading provider ...

The recent clearance reconfirms the freedom to utilize the entire volume of EQUASHIELD's Syringe Unit, leading to enhanced cost savings and safety with handling of hazardous drugs. PORT WASHINGTON, ...